Albumin-bound Paclitaxel、Dalpiciclib and AI in ER-Low (1%-10%) HER2-ABC
NCT06711094
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
52
Enrollment
OTHER
Sponsor class
Conditions
HR+/HER2- Advanced Breast Cancer
Interventions
DRUG:
Dalpiciclib
Sponsor
Fujian Medical University